These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7549169)

  • 1. Moclobemide in chronic neuropathic pain: preliminary case reports.
    Menkes DB; Fawcett JP; Busch AF; Jones D
    Clin J Pain; 1995 Jun; 11(2):134-8. PubMed ID: 7549169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide].
    Coquoz D; Porchet HC; Dayer P
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1843-5. PubMed ID: 1754870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled trial of moclobemide in social phobia.
    Schneier FR; Goetz D; Campeas R; Fallon B; Marshall R; Liebowitz MR
    Br J Psychiatry; 1998 Jan; 172():70-7. PubMed ID: 9534836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model.
    Villarinho JG; Pinheiro Kde V; Pinheiro Fde V; Oliveira SM; Machado P; Martins MA; Bonacorso HG; Zanatta N; Fachinetto R; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():136-42. PubMed ID: 23419243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
    Duarte A; Mikkelsen H; Delini-Stula A
    J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R).
    Newburn G; Edwards R; Thomas H; Collier J; Fox K; Collins C; Cramer D; Reeves J; Caracatsanis A
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M; Nardi AE; Mundim FD; Alves AB
    J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy.
    Toth C
    Pain Med; 2010 Mar; 11(3):456-65. PubMed ID: 20113408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
    Backonja M; Glanzman RL
    Clin Ther; 2003 Jan; 25(1):81-104. PubMed ID: 12637113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression.
    Tanghe A; Geerts S; Van Dorpe J; Brichard B; Bruhwyler J; Géczy J
    Acta Psychiatr Scand; 1997 Aug; 96(2):134-41. PubMed ID: 9272198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease.
    Sternic N; Kacar A; Filipovic S; Svetel M; Kostic VS
    Clin Neuropharmacol; 1998; 21(2):93-6. PubMed ID: 9579294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical overview on moclobemide.
    Tiller JW
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):703-12. PubMed ID: 8255982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moclobemide in the prophylactic treatment of migraine. A retrospective analysis of 44 cases.
    Meienberg O; Amsler F
    Eur Neurol; 1996; 36(2):109-10. PubMed ID: 8654481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventive treatment of migraine and chronic tension headache with moclobemide].
    Meienberg O; Amsler F
    Praxis (Bern 1994); 1997 Jul; 86(27-28):1107-12. PubMed ID: 9324719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
    Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
    Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between moclobemide and oral tyramine in depressed patients.
    Burgess CD; Mellsop GW
    Fundam Clin Pharmacol; 1989; 3(1):47-52. PubMed ID: 2714732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.